Development of the Weight and Emotions Scale (WES)

The WES may be used in clinical trials, observational research, or clinical practice to robustly assess the impact of obesity or overweight and the benefits of treatment on patients' emotional functioning.

Authors

Chisom Kanu (ORCID: https://orcid.org/0000-0002-2621-8652)
Miriam Kimel
Marissa Stefan
Jessica Jordan
Lisa M. Neff
Iris Goetz
Kristina S. Boye

Institutions

Eli Lilly (United States) (US)
Thermo Fisher Scientific (United States) (US)

Publication Details

Journal: Obesity Science & Practice
Published: 2026-01-25
DOI: https://doi.org/10.1002/osp4.70119
Primary Topic: Bariatric Surgery and Outcomes
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Eli Lilly and Company

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Development of the Weight and Emotions Scale (WES)

Chisom Kanu, Miriam Kimel, Marissa Stefan, Jessica Jordan et al.

Jan 25, 2026

Obesity Science & Practice

Bariatric Surgery and Outcomes

article

Development of the Weight and Emotions Scale (WES)

Chisom Kanu, Miriam Kimel, Marissa Stefan, Jessica Jordan, Lisa M. Neff, Iris Goetz, Kristina S. Boye

January 25, 2026article en

Abstract

Obesity Science & PracticeVol. 12(1)

Eli Lilly (United States) (US), Thermo Fisher Scientific (United States) (US)

Eli Lilly and Company

Openalex Percentile: Top 78%

Bariatric Surgery and Outcomes

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.